A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...
Gilead has grown to become a leader in the fight against HIV and has announced efforts to improve access to a new, highly ...
Winnie Byanyima, from UNAIDS: ‘Lenacapavir is more effective than condoms or PrEP in prevention’
The executive director of the organization says gender inequality is one of the most important drivers of new infections, ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
The Executive Director of UNAIDS Winnie Byanyima is calling for accelerated global solidarity to strengthen Madagascar's response to HIV, including preventing new HIV infections and expanding access ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Mann, PhD, MPH, from the US Centers for Disease Control and Prevention in Atlanta ... Generic TDF/FTC reached the highest monthly share of users among all medications from December 2021 to December ...
Zacks.com on MSN2d
Gilead, MRK Report Data From Investigational Combination Study for HIVGilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...
Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, according to a research letter published online Oc ...
With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback